Newsroom

[The Washington Post] How do you pay for a drug that costs $84,000?

“As longtime health-care advocate John Rother sees it, the Sovaldi issue is a turning point for the health-care system, making it confront the biggest questions: how […]

Read more

[Bloomberg News] U.S. Senators Ask Gilead to Explain $84,000 Hep C Drug Pricing

Gilead Sciences Inc. has been asked by two U.S. senators to explain how it priced its $84,000 hepatitis C treatment Sovaldi, adding pressure on the drugmaker to […]

Read more

[Politico] Wyden, Grassley want answers on Sovaldi

By: Brett Norman A bipartisan pair of senators is asking the pharmaceutical company that makes a hepatitis C “miracle drug” to justify its $84,000 per treatment price […]

Read more

[The Hill] Wyden, Grassley question hep C drug’s high cost

Two high-ranking senators have lent their voices to the chorus demanding to know why Gilead’s new hepatitis C drug Sovaldi costs $1,000 a pill. Sens. Ron […]

Read more